| 产品详情 |
| Edit |   |
|---|
| Product Name | LY500307 |
|---|
| Description | MW: 282.33. |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | [LY500307] |
|---|
| Catalog # | MBS8506417 |
|---|
| Price | |
|---|
| Order / More Info | LY500307 from MYBIOSOURCE INC. |
|---|
| Product Specific References | LY500307 is a potent, selective estrogen receptor beta agonist with an EC50 of 0.66 nM. LY500307 is selective (32-fold) toward ERbeta and shows full agonist function in both ERalpha and ERbeta assays (90% relative efficacy). [1] LY500307 is a drug used to treat prostate diseases. A phase 2 clinical study was carried out to evaluate daily oral doses of LY500307 for 24 weeks in men with lower urinary tract symptoms (LUTS) and prostatic enlargement secondary to benign prostatic hyperplasia (BPH). [ |
|---|
| 产品资料 |
|
|